Congress Asset Management Co. Sells 69,814 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Congress Asset Management Co. reduced its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,088,062 shares of the medical device company's stock after selling 69,814 shares during the period. Congress Asset Management Co. owned approximately 0.54% of Cooper Companies worth $91,778,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Byrne Asset Management LLC purchased a new position in shares of Cooper Companies in the 4th quarter worth $33,000. OFI Invest Asset Management purchased a new position in Cooper Companies during the fourth quarter valued at $34,000. New Age Alpha Advisors LLC purchased a new position in Cooper Companies during the fourth quarter valued at $38,000. Covestor Ltd lifted its position in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares in the last quarter. Finally, Atala Financial Inc purchased a new position in Cooper Companies during the fourth quarter valued at $51,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Shares of COO stock traded up $1.15 during trading hours on Friday, hitting $72.33. The stock had a trading volume of 4,093,480 shares, compared to its average volume of 1,595,301. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The stock's 50-day moving average price is $78.35 and its two-hundred day moving average price is $87.22. The stock has a market capitalization of $14.46 billion, a price-to-earnings ratio of 37.09, a PEG ratio of 2.25 and a beta of 0.98.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. During the same period in the previous year, the firm posted $0.85 earnings per share. The firm's revenue for the quarter was up 6.3% on a year-over-year basis. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

COO has been the topic of several analyst reports. Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Stifel Nicolaus lowered their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a research report on Friday, May 30th. Finally, Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Thursday, May 22nd. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $100.38.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.